Fig. 6. Regulatory mechanisms of natural drugs targeting ferroptosis in lung cancer.
ART Artesunate, DHA Dihydroartemisinin, CUL Curcumenol, CEL Celastrol, BE Betulin, SAG Sanguinarine, SI Sinapine, SS Solasonine, CAP Capsaicin, ERI Erianin, DT Dihydroisotanshinone I, CTS Cryptotanshinone, OP-B Ophiopogonin-B, GK Ginkgetin, BT Bufotalin, SFN Sulforaphane, RGP Red ginseng polysaccharide, SLC40A1 solute carrier family 40 member 1, HO-1 Heme oxygenase 1, LC3 microtubule-associated protein 1 light chain, ATG5 autophagy-related protein 5, ATG7 autophagy-related protein 7, PRIM2 DNA primase polypeptide 2, FIS1 mitochondrial adaptor fission 1, DRP1 dynamin related protein 1, FTH1 ferritin heavy chain 1, AURKA Aurora kinase A, USP11 ubiquitin-specific processing protease 11, MMP mitochondrial membrane potential, miRNA MicroRNA, lncRNA Long non-coding RNA, DMT1 solute carrier family 11 member 2, Nrf2 nuclear factor erythroid 2-related factor 2, p53 tumor suppressor protein, GPX4 glutathione peroxidase 4, System Xc− cystine/glutamate antiporter system, Cys2 cystine, Glu glutamate, Cys cysteine, Gly glycine, GCL glutamate-cysteine ligase, SLC3A2 solute carrier family 3, member 2, SLC7A11 solute carrier family 7 (L-type amino acid transporter), member 11, GSS glutathione synthetase, GSH glutathione, GSSG oxidized glutathione, GSR glutathione reductase, ROS reactive oxygen species.